contact
Get In Touch
Connect with our specialists to discuss your treatment approach, patient needs, and how our advanced solutions can support better outcomes.
Support@osteo.de
HO
GmbH
Hildebrandstr. 11
90592 Schwarzenbruck | Germany
FMG
Facility UNNA II | Production
Isaac-Newton-Str. 7
59423 Unna | Germany
I'm Here to Help
At Premium Pro, we partner with orthopedic specialists to support clinical decision-making and optimize patient outcomes in osteoarthritis management.
Our team provides dedicated support on product selection, intra-articular application protocols, and integration into existing treatment pathways. We understand the challenges of managing joint degeneration, pain control, and functional recovery — and we aim to deliver solutions that align with real clinical practice.
Whether you are evaluating Osteo Pro for the first time or incorporating it into your therapeutic approach, our specialists are available to provide evidence-informed guidance tailored to your patients and treatment goals.
Which patients are most suitable for Osteo Pro?
Osteo Pro is indicated for patients with symptomatic mild to moderate knee osteoarthritis (Kellgren–Lawrence grade I–III), particularly those with suboptimal response to conservative therapies such as NSAIDs, physiotherapy, or standard viscosupplementation.
How does Osteo Pro differ from conventional HA injections?
Osteo Pro integrates cross-linked and linear hyaluronic acid with PDRN and human placenta extract, providing a multi-modal mechanism targeting viscoelastic restoration, inflammatory modulation, and cellular activity within the joint microenvironment.
What is the recommended administration protocol?
Osteo Pro is administered as a single intra-articular injection under aseptic conditions by a qualified healthcare professional. Standard injection techniques for knee OA should be followed.
What clinical benefits can be expected?
The formulation is designed to provide sustained pain relief, improved joint function, and support of cartilage homeostasis through combined mechanical and biological pathways.
Are there specific patient profiles that require caution?
Yes. Caution is advised in patients with advanced osteoarthritis, known hypersensitivity to product components, coagulation disorders, or those receiving anticoagulant therapy.
Which patients are most suitable for Osteo Pro?
Osteo Pro is indicated for patients with symptomatic mild to moderate knee osteoarthritis (Kellgren–Lawrence grade I–III), particularly those with suboptimal response to conservative therapies such as NSAIDs, physiotherapy, or standard viscosupplementation.
How does Osteo Pro differ from conventional HA injections?
Osteo Pro integrates cross-linked and linear hyaluronic acid with PDRN and human placenta extract, providing a multi-modal mechanism targeting viscoelastic restoration, inflammatory modulation, and cellular activity within the joint microenvironment.
What is the recommended administration protocol?
Osteo Pro is administered as a single intra-articular injection under aseptic conditions by a qualified healthcare professional. Standard injection techniques for knee OA should be followed.
What clinical benefits can be expected?
The formulation is designed to provide sustained pain relief, improved joint function, and support of cartilage homeostasis through combined mechanical and biological pathways.
Are there specific patient profiles that require caution?
Yes. Caution is advised in patients with advanced osteoarthritis, known hypersensitivity to product components, coagulation disorders, or those receiving anticoagulant therapy.